CRH Gene
Introduction
Crh Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene"> [@heinrichs2004]
<div class="infobox-header">CRH</div> [@hauger2006]
<div class="infobox-row"><strong>Full Name:</strong> Corticotropin-Releasing Hormone</div> [@rothman2022]
<div class="infobox-row"><strong>Chromosome:</strong> 8q13</div> [@arborelius1999]
<div class="infobox-row"><strong>NCBI Gene ID:</strong> [1399](https://www.ncbi.nlm.nih.gov/gene/1399)</div> [@bale2004]
<div class="infobox-row"><strong>Ensembl ID:</strong> [ENSG00000118271](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000118271)</div> [@laryea2020]
<div class="infobox-row"><strong>OMIM:</strong> [122560](https://www.omim.org/entry/122560)</div> [@zorrilla2010]
<div class="infobox-row"><strong>UniProt:</strong> [P06850](https://www.uniprot.org/uniprot/P06850)</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Depression, Anxiety, PTSD, Cushing's Disease</div>
<div class="infobox-row"><strong>Protein Class:</strong> Neuropeptide hormone, GPCR ligand</div>
<div class="infobox-row"><strong>Brain Expression:</strong> High in paraventricular nucleus, amygdala, hippocampus</div>
</div>
Pathway Diagram
...CRH Gene
Introduction
Crh Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene"> [@heinrichs2004]
<div class="infobox-header">CRH</div> [@hauger2006]
<div class="infobox-row"><strong>Full Name:</strong> Corticotropin-Releasing Hormone</div> [@rothman2022]
<div class="infobox-row"><strong>Chromosome:</strong> 8q13</div> [@arborelius1999]
<div class="infobox-row"><strong>NCBI Gene ID:</strong> [1399](https://www.ncbi.nlm.nih.gov/gene/1399)</div> [@bale2004]
<div class="infobox-row"><strong>Ensembl ID:</strong> [ENSG00000118271](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000118271)</div> [@laryea2020]
<div class="infobox-row"><strong>OMIM:</strong> [122560](https://www.omim.org/entry/122560)</div> [@zorrilla2010]
<div class="infobox-row"><strong>UniProt:</strong> [P06850](https://www.uniprot.org/uniprot/P06850)</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Depression, Anxiety, PTSD, Cushing's Disease</div>
<div class="infobox-row"><strong>Protein Class:</strong> Neuropeptide hormone, GPCR ligand</div>
<div class="infobox-row"><strong>Brain Expression:</strong> High in paraventricular nucleus, amygdala, hippocampus</div>
</div>
Pathway Diagram
Mermaid diagram (expand to render)
Overview
Corticotropin-releasing hormone (CRH), also known as corticotropin-releasing factor (CRF), is a 41-amino acid neuropeptide that serves as the primary regulator of the hypothalamic-pituitary-adrenal (HPA) axis and a major coordinator of stress responses throughout the body[@vale1981]. The CRH gene on chromosome 8q13 encodes this critical neuropeptide, which is essential for survival under acute stress conditions but becomes dysregulated in chronic stress states associated with neurodegenerative diseases.
Normal Function
The CRH gene encodes prepro-CRH, a precursor peptide that is processed to mature CRH. CRH is primarily synthesized in the paraventricular nucleus (PVN) of the hypothalamus but is also produced in extrahypothalamic brain regions[@heinrichs2004].
Neuroendocrine Regulation
- Stimulates ACTH release from anterior pituitary
- Coordinates HPA axis response to stress
- Regulates cortisol and corticosterone secretion
- Controls glucocorticoid feedback
Stress Response
- Initiates cascade of stress hormone release
- Modulates arousal and attention
- Affects fear and anxiety processing
- Regulates autonomic responses
Central Nervous System Functions
- CRH acts as neurotransmitter in limbic system
- Modulates emotional processing and memory
- Influences food intake and metabolism
- Regulates sleep-wake cycles
Expression Pattern
CRH is expressed in brain regions involved in stress and emotion:
| Brain Region | Expression Level | Functional Significance |
|--------------|------------------|------------------------|
| Hypothalamus (PVN) | Very High | HPA axis regulation |
| Amygdala (CeA) | High | Fear, anxiety |
| Hippocampus | Moderate | Memory, stress effects |
| Prefrontal [Cortex](/brain-regions/cortex) | Moderate | Executive function |
| Bed Nucleus of Stria Terminalis | High | Stress-induced behavior |
| Locus Coeruleus | Moderate | Arousal, attention |
Molecular Mechanisms
CRH signals through two G-protein coupled receptors, CRHR1 and CRHR2, with distinct expression patterns and functions[@hauger2006]:
Receptor Signaling
- CRHR1: Primary mediator of stress responses, anxiety; Gi-coupled, inhibits adenylate cyclase
- CRHR2: Mediates anxiolytic effects, involved in stress adaptation; similar signaling pathways
Downstream Pathways
- cAMP/PKA pathway activation
- MAPK/ERK pathway modulation
- Calcium channel regulation
- Gene transcription changes via CREB
CRH-Binding Protein (CRH-BP)
- Circulating and extracellular protein
- Modulates CRH availability
- Potential therapeutic target
Disease Associations
Alzheimer's Disease
CRH system dysregulation is implicated in AD pathogenesis[@rothman2022]. Chronic stress and elevated cortisol may accelerate amyloid deposition and [tau](/proteins/tau) pathology. CRH receptor modulators are being explored as potential therapeutics.
Parkinson's Disease
CRH alterations contribute to non-motor symptoms in PD, including depression, anxiety, and sleep disorders. The stress-CRH axis affects dopaminergic neuron survival.
Depression and Anxiety
CRH overactivity is a key feature of major depression and anxiety disorders. CRHR1 antagonists show antidepressant and anxiolytic potential in clinical trials.
PTSD
CRH system abnormalities persist in PTSD, contributing to hyperarousal and stress reactivity. CRH modulation represents a therapeutic strategy.
Cushing's Disease
CRH-producing pituitary adenomas cause ACTH-dependent Cushing's syndrome. CRH stimulation testing is used diagnostically.
Therapeutic Implications
CRH Receptor Antagonists
| Drug/Compound | Target | Development Stage | Potential Application |
|--------------|--------|------------------|----------------------|
| Peptide antagonists | CRHR1/CRHR2 | Preclinical | Anxiety, depression |
| Small molecule antagonists | CRHR1 | Clinical trials | Depression, PTSD |
| Antalarmin | CRHR1 | Preclinical | Stress, anxiety |
| CP-154,526 | CRHR1 | Preclinical | Depression, anxiety |
Approaches Under Investigation
- CRHR1 selective antagonists for neurodegeneration
- CRH-BP modulators
- Gene therapy for CRH dysregulation
- Peptide analogs with improved stability
Clinical Applications
- CRH stimulation test for Cushing's diagnosis
- CRH antagonists for treatment-resistant depression
- Stress reduction interventions
Research Directions
CRHR1 Selectivity: Developing highly selective CRHR1 antagonists
[Blood-Brain Barrier](/entities/blood-brain-barrier): Creating brain-penetrant compounds
Stress-Neurodegeneration Link: Understanding chronic stress effects
Biomarkers: CRH as marker of HPA axis dysfunction
Gene Therapy: AAV-based CRH modulationAnimal Models
Knockout Mice
- CRH knockout mice show impaired stress response
- CRHR1 knockout mice display reduced anxiety
- CRHR2 knockout mice show enhanced stress responses
Transgenic Models
- CRH overexpression: stress-sensitive phenotype
- CRHR1/CRHR2 conditional knockouts
- Disease models with CRH system modifications
Rodent Studies
- Chronic stress models and CRH effects
- CRH infusion studies
- Receptor localization studies
Clinical Relevance
CRH system modulation has therapeutic potential:
- Neurodegeneration: Modulating stress effects on disease progression
- Psychiatric: Depression, anxiety, PTSD treatment
- Metabolic: Effects on energy balance
- Inflammatory: Interactions with immune system
See Also
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Hypothalamus](/brain-regions/hypothalamus)
- [Amygdala](/cell-types/basolateral-amygdala)
- [Hippocampus](/brain-regions/hippocampus)
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
External Links
- [NCBI Gene: CRH](https://www.ncbi.nlm.nih.gov/gene/1399)
- [UniProt: CRH](https://www.uniprot.org/uniprot/P06850)
- [Ensembl: CRH](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000118271)
- [Human Protein Atlas: CRH](https://www.proteinatlas.org/gene/CRH)
Background
The study of Crh Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Vale W, Spiess J, Rivier C, Rivier J, Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin (1981)](https://pubmed.ncbi.nlm.nih.gov/6267699/)
[Heinrichs SC, Koob GF, Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation (2004)](https://pubmed.ncbi.nlm.nih.gov/15266053/)
[Hauger RL, Risbrough V, Brauns O, Dautzenberg FM, Corticotropin releasing factor receptors and CRF binding protein: role in stress and anxiety (2006)](https://pubmed.ncbi.nlm.nih.gov/16787254/)
[Rothman RB, Dersch CM, Fragment M, et al, Corticotropin releasing factor and the stress response in neurodegenerative disease (2022)](https://pubmed.ncbi.nlm.nih.gov/34826631/)
[Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB, The role of corticotropin-releasing factor in depression and anxiety disorders (1999)](https://pubmed.ncbi.nlm.nih.gov/9854971/)
[Bale TL, Vale WW, CRF and CRF receptors: role in stress responsivity and other behaviors (2004)](https://pubmed.ncbi.nlm.nih.gov/14744245/)
[Laryea G, Arnett M, McGhee E, et al, Corticotropin-releasing factor and neuroinflammation (2020)](https://pubmed.ncbi.nlm.nih.gov/31760073/)
[Zorrilla EP, Koob GF, Progress in corticotropin-releasing factor-1 receptor antagonist development (2010)](https://pubmed.ncbi.nlm.nih.gov/20362641/)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Multi-Modal Stress Response Harmonization](/hypothesis/h-1e564178) — <span style="color:#81c784;font-weight:600">0.61</span> · Target: NR3C1/CRH/TNFA
Pathway Diagram
The following diagram shows the key molecular relationships involving CRH Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)